Skip to main content
OpenTrials

Clinical trial condition

Aggressive Non-Hodgkin Lymphoma

Explore clinical trials studying Aggressive Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

14 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Aggressive Non-Hodgkin Lymphoma trial results

Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

NCT03458260

Conditions
Aggressive Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • AZ Sint Jan Bruges, Belgium
  • Institut Jules Bordet - Centre des tumeurs de l'ULB Brussels, Belgium
  • Centre Hospitalier de Jolimont Haine-Saint-Paul, Belgium
  • CH d'Avignon Avignon, France
View all 22 locations
View Trial Details
Completed

Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas

NCT03161054

Conditions
Aggressive Non-Hodgkin Lymphoma
Locations
  • A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
  • Ospedale di Castelfranco Veneto - Ematologia Castelfranco Veneto, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia Meldola, Italy
  • Ospedale Guglielmo da Saliceto - U.O.Ematologia Piacenza, Italy
View Trial Details
Completed

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

NCT00789776

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
  • Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

NCT00723099

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details

Related conditions